Count | |
| 3 | |
| 2 | |
Piperazines/adverse effects/pharmacokinetics/*therapeutic use | 3 |
| 1 | |
| 1 | |
| 1 | |
Piperazines/administration & dosage/adverse effects/*pharmacology | 1 |
Piperazines/adverse effects/*chemical synthesis/chemistry/pharmacology | 1 |
| 47 | |
| 19 | |
| 1 | |
| 1 | |
| 5 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 18 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 6 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 11 | |
| 10 | |
| 1 | |
| 9 | |
| 1 | |
| 7 | |
| 7 | |
| 2 | |
| 1 | |
| 33 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 8 | |
| 1 | |
| 8 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 2 | |
| 6 | |
| 7 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |